| Copies/mL | Pre-HCT | Month 1 | Month 2 | Month 3 | Month 4 | Month 8 | Month 12 | Month 24 |
| n = 174 | n = 162 | n = 146 | n = 128 | n = 99 | n = 63 | n = 81 | n = 37 | |
| 0 | 105 (60.3%) | 17 (10.5%) | 23 (15.8%) | 20 (15.6%) | 26 (26.3%) | 43 (68.3%) | 52 (64.2%) | 24 (64.9%) |
| 1–999 999 999 | 63 (36.2%) | 65 (40.1%) | 51 (34.9%) | 53 (41.4%) | 37 (37.4%) | 15 (23.8%) | 21 (25.9%) | 11 (29.7%) |
| ≥106–109 | 6 (3.5%) | 21 (13.0%) | 32 (21.9%) | 27 (21.1%) | 24 (24.2%) | 3 (4.8%) | 6 (7.4%) | 2 (5.4%) |
| ≥109 | 0 (0%) | 59 (36.4%) | 40 (27.4%) | 28 (21.9%) | 12 (12.1%) | 2 (3.2%) | 2 (2.5%) | 0 (0%) |
| Copies/mL | Pre-HCT | Month 1 | Month 2 | Month 3 | Month 4 | Month 8 | Month 12 | Month 24 |
| n = 174 | n = 162 | n = 146 | n = 128 | n = 99 | n = 63 | n = 81 | n = 37 | |
| 0 | 105 (60.3%) | 17 (10.5%) | 23 (15.8%) | 20 (15.6%) | 26 (26.3%) | 43 (68.3%) | 52 (64.2%) | 24 (64.9%) |
| 1–999 999 999 | 63 (36.2%) | 65 (40.1%) | 51 (34.9%) | 53 (41.4%) | 37 (37.4%) | 15 (23.8%) | 21 (25.9%) | 11 (29.7%) |
| ≥106–109 | 6 (3.5%) | 21 (13.0%) | 32 (21.9%) | 27 (21.1%) | 24 (24.2%) | 3 (4.8%) | 6 (7.4%) | 2 (5.4%) |
| ≥109 | 0 (0%) | 59 (36.4%) | 40 (27.4%) | 28 (21.9%) | 12 (12.1%) | 2 (3.2%) | 2 (2.5%) | 0 (0%) |
There were 189 participants with at least 1 urine sample tested for viruria: n represents the number of participants tested at each time point.
Abbreviation: HCT, hematopoietic cell transplant.
| Copies/mL | Pre-HCT | Month 1 | Month 2 | Month 3 | Month 4 | Month 8 | Month 12 | Month 24 |
| n = 174 | n = 162 | n = 146 | n = 128 | n = 99 | n = 63 | n = 81 | n = 37 | |
| 0 | 105 (60.3%) | 17 (10.5%) | 23 (15.8%) | 20 (15.6%) | 26 (26.3%) | 43 (68.3%) | 52 (64.2%) | 24 (64.9%) |
| 1–999 999 999 | 63 (36.2%) | 65 (40.1%) | 51 (34.9%) | 53 (41.4%) | 37 (37.4%) | 15 (23.8%) | 21 (25.9%) | 11 (29.7%) |
| ≥106–109 | 6 (3.5%) | 21 (13.0%) | 32 (21.9%) | 27 (21.1%) | 24 (24.2%) | 3 (4.8%) | 6 (7.4%) | 2 (5.4%) |
| ≥109 | 0 (0%) | 59 (36.4%) | 40 (27.4%) | 28 (21.9%) | 12 (12.1%) | 2 (3.2%) | 2 (2.5%) | 0 (0%) |
| Copies/mL | Pre-HCT | Month 1 | Month 2 | Month 3 | Month 4 | Month 8 | Month 12 | Month 24 |
| n = 174 | n = 162 | n = 146 | n = 128 | n = 99 | n = 63 | n = 81 | n = 37 | |
| 0 | 105 (60.3%) | 17 (10.5%) | 23 (15.8%) | 20 (15.6%) | 26 (26.3%) | 43 (68.3%) | 52 (64.2%) | 24 (64.9%) |
| 1–999 999 999 | 63 (36.2%) | 65 (40.1%) | 51 (34.9%) | 53 (41.4%) | 37 (37.4%) | 15 (23.8%) | 21 (25.9%) | 11 (29.7%) |
| ≥106–109 | 6 (3.5%) | 21 (13.0%) | 32 (21.9%) | 27 (21.1%) | 24 (24.2%) | 3 (4.8%) | 6 (7.4%) | 2 (5.4%) |
| ≥109 | 0 (0%) | 59 (36.4%) | 40 (27.4%) | 28 (21.9%) | 12 (12.1%) | 2 (3.2%) | 2 (2.5%) | 0 (0%) |
There were 189 participants with at least 1 urine sample tested for viruria: n represents the number of participants tested at each time point.
Abbreviation: HCT, hematopoietic cell transplant.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
